Page last updated: 2024-12-05

1,3-cyclopentadiene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-Cyclopentadiene is a highly reactive, colorless liquid with a pungent odor. It is a cyclic diene, meaning it contains two double bonds within a ring structure. It is known for its tendency to undergo Diels-Alder reactions, a type of cycloaddition reaction, serving as a key reactant in organic synthesis for generating six-membered ring systems. The compound is readily synthesized from the thermal cracking of dicyclopentadiene, a dimeric form of cyclopentadiene. Its importance lies in its role as a building block in the synthesis of complex organic molecules, polymers, and pharmaceuticals. Researchers study its behavior to understand the intricate mechanisms of chemical reactions and the formation of new molecular structures. 1,3-Cyclopentadiene is also of interest in the field of materials science for its potential in developing new materials with unique properties.'

1,3-cyclopentadiene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7612
CHEMBL ID3188826
CHEBI ID30664
MeSH IDM0045852

Synonyms (35)

Synonym
cyclopentadiene
einecs 208-835-4
r-pentine
hsdb 2514
pyropentylene
pentole
542-92-7
CHEBI:30664 ,
1,3-cyclopentadiene
inchi=1/c5h6/c1-2-4-5-3-1/h1-4h,5h
cyclopenta-1,3-diene
GHL.PD_MITSCHER_LEG0.1205
FT-0656719
FT-0659414
dtxcid007191
cas-542-92-7
NCGC00255341-01
tox21_302134
dtxsid0027191 ,
A818675
26912-33-4
unii-5dfh9434hf
5dfh9434hf ,
ec 208-835-4
AKOS025295445
cyclopentadiene [mi]
1,3-cyclopentadiene [hsdb]
cyclo pentadiene
cyclopentadien
cyclo-pentadiene
CHEMBL3188826
Q424390
Q2209035
1.3-cyclopentadiene pound dimer form pound(c)
AT31522

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" We also investigated its bioavailability in humans and its anti-inflammatory effect ex vivo."( META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
Austin, M; Bland, JS; Carroll, BJ; Darland, G; Desai, A; Konda, VR; Prabhu, KS; Tripp, ML, 2009
)
0.35
" Bioavailability was tested in 4 human subjects consuming 940 mg META060."( META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
Austin, M; Bland, JS; Carroll, BJ; Darland, G; Desai, A; Konda, VR; Prabhu, KS; Tripp, ML, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cycloalkadieneAn unsaturated monocyclic hydrocarbon having two endocyclic double bonds.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency61.13060.003041.611522,387.1992AID1159552
farnesoid X nuclear receptorHomo sapiens (human)Potency21.87240.375827.485161.6524AID743220
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's4 (36.36)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.26 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index61.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]